Alpha-MSH analog GKPV immobilized on surfaces inhibited TNF-α-stimulated NF-κB activation in cells, demonstrating that KPV-related peptides retain anti-inflammatory activity when attached to biomaterial surfaces — enabling anti-inflammatory medical device coatings.
Key findingGKPV (alpha-MSH 10-13) immobilized on surfaces retained NF-κB inhibitory activity against TNF-α-stimulated inflammation in vitro, demonstrating that K
What the researchers found
GKPV (alpha-MSH 10-13) immobilized on surfaces retained NF-κB inhibitory activity against TNF-α-stimulated inflammation in vitro, demonstrating that KPV-related peptides can function as bioactive anti-inflammatory coatings for medical devices and implants.
Why it matters
Relevant for kpv, inflammation.
How the study worked
in-vitro study on kpv, inflammation.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2006.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity.
Peptides, 27(2), 431-7
Citation
Kelly, J M; Moir, A J G; Carlson, K; Yang, Y; MacNeil, S; Haycock, J W. (2006). Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity.. Peptides, 27(2), 431-7.